FibroBiologics (FBLG) Shares Outstanding (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Shares Outstanding (Entity) of $6.7 million for Q2 2026, up 225.88% year-over-year from $2.0 million in Q2 2025, and up 89.52% on a QoQ basis from $3.5 million in Q1 2026.
FibroBiologics (FBLG) Shares Outstanding (2022 - 2026) Analysis & Trends
FibroBiologics has reported Shares Outstanding (Entity) for 5 years, with the latest figure at $6.7 million in Q2 2026.
- Shares Outstanding (Entity) for Q2 2026 came in at $6.7 million, up 225.88% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.7 million (up 225.88% YoY), and the FY2025 annual result was $2.2 million, up 27.29% from the prior year.
- Shares Outstanding (Entity) rose to $6.7 million in Q2 2026, from $3.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $6.7 million in Q2 2026 and troughed at $1.4 million in Q4 2022.
- A 5-year average of $2.2 million and a median of $1.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2023, when Shares Outstanding (Entity) changed 0.0%; it then jumped 225.88% in 2026.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $1.4 million in 2022, then changed by 0.0% to $1.4 million in 2023, then rose by 24.28% to $1.8 million in 2024, then increased by 27.29% to $2.2 million in 2025, then jumped by 198.17% to $6.7 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $6.7 million in Q2 2026, $3.5 million in Q1 2026, and $2.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.27 Mn |
| Mar 31, 2026 | 3.77 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.41 Mn |